5-Chloro-N-(3,5-dimethoxybenzyl)-2,4-difluoro-N-(5-fluorothiazol-2-yl)benzenesulfonamide, 98%, 250mg

Methyl 2,3-diamino-6-methylbenzoate, 98%, 500mg

(S)-3-Aminopyrrolidin-2-one hydrochloride, 95.0%, 5g

3-Methyl-3,4-dihydro-2H-1,4-benzoxazine, 95.0%, 100mg

(6-Isopropoxypyridin-3-yl)boronic acid, 95.0%, 25g

5-Ethynyl-UTP, ≥95%, 10 µl, emballage plastique.

6-Bromo-3-chloro-2-fluorobenzaldehyde, 95.0%, 250mg

Symbole d'avertissement selon ISO 7010 Étiquette individuelle, Rayonnement optique, Longueur de côté 100 mm, 1 pièce

1,3,5-Triaza-7-phosphaadamantane, 95.0%, 1g

1-Ethyl-1H-benzimidazole-2-sulfonic acid, 95.0%, 1g

2-(tert-Butyl)-3-methyl-2H-indazole-6-carboxylic acid, 95.0%, 1g

2,3,5-Trifluorobenzaldehyde, 97.0%, 5g

2-Bromo-8-chlorodibenzo[b,d]furan, 98%, 250mg